Maxygen Financial Statements
Maxygen Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Maxygen Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 23.2 | 25.0 | 14.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (56.9) | (41.7) | (40.6) |
| Total Net Income ($ mil.) | (49.3) | (16.5) | (18.4) |
| Diluted EPS (Net Income) | (1.34) | (0.46) | (0.52) |
Maxygen Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1.2 | 1.4 | 11.0 |
| Gross Profit ($ mil.) | 14.3 | (11.7) | -- |
| Operating Income ($ mil.) | (28.9) | (15.7) | (12.7) |
| Total Net Income ($ mil.) | (28.1) | (13.7) | (11.3) |
| Diluted EPS (Net Income) | (0.76) | (0.37) | (0.30) |
Maxygen Stock Quote & Chart
09/05/08 10:18:13 EST •
NASDAQ •
4.29
•
 -0.2100
•
-4.6667 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Maxygen Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 13.62 | 1.48 | 1.56 |
| Price/Earnings Ratio | -- | 22.56 | 15.82 |
| Price/Book Ratio | 1.71 | 2.77 | 1.52 |
| Price/Cash Flow Ratio | -- | 14.73 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Maxygen Financial Ratios
Maxygen Competitive Intelligence
| Eli Lilly | Genentech | Human Genome Sciences | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 11,724.0 | 41.8 |
| Employees | 40,600 | 11,174 | -- |
| Market Cap ($ mil.) | 54,960.2 | 104,308.8 | 1,043.7 |
Competitive Landscape
